192 related articles for article (PubMed ID: 24001451)
41. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
42. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
[TBL] [Abstract][Full Text] [Related]
43. CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma.
Sakamoto M; Miyagaki T; Kamijo H; Oka T; Boki H; Takahashi-Shishido N; Suga H; Sugaya M; Sato S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360654
[TBL] [Abstract][Full Text] [Related]
44. Thymus and activation-regulated chemokine in different stages of mycosis fungoides: tissue and serum levels.
Abou El-Ela M; El-Rifae Ael-A; Fawzi M; Abdel Hay R; Gohary Y; Shaker O
Australas J Dermatol; 2011 Aug; 52(3):167-71. PubMed ID: 21834810
[TBL] [Abstract][Full Text] [Related]
45. Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis.
Oka T; Sugaya M; Takahashi N; Nakajima R; Otobe S; Kabasawa M; Suga H; Miyagaki T; Asano Y; Sato S
Acta Derm Venereol; 2017 Nov; 97(10):1172-1177. PubMed ID: 28597022
[TBL] [Abstract][Full Text] [Related]
46. Analysis of eotaxin 1/CCL11, eotaxin 2/CCL24 and eotaxin 3/CCL26 expression in lesional and non-lesional skin of patients with atopic dermatitis.
Owczarek W; Paplińska M; Targowski T; Jahnz-Rózyk K; Paluchowska E; Kucharczyk A; Kasztalewicz B
Cytokine; 2010 May; 50(2):181-5. PubMed ID: 20236835
[TBL] [Abstract][Full Text] [Related]
47. Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets.
Saulite I; Hoetzenecker W; Weidinger S; Cozzio A; Guenova E; Wehkamp U
Biomed Res Int; 2016; 2016():9717530. PubMed ID: 27294147
[TBL] [Abstract][Full Text] [Related]
48. Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome.
Klemke CD; Mansmann U; Poenitz N; Dippel E; Goerdt S
Br J Dermatol; 2005 Jul; 153(1):118-24. PubMed ID: 16029336
[TBL] [Abstract][Full Text] [Related]
49. Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment.
Yatagai T; Shimauchi T; Yamaguchi H; Sakabe JI; Aoshima M; Ikeya S; Tatsuno K; Fujiyama T; Ito T; Ojima T; Tokura Y
J Dermatol Sci; 2018 Jan; 89(1):33-39. PubMed ID: 29122406
[TBL] [Abstract][Full Text] [Related]
50. Atopy, IgE and eosinophilic cationic protein concentration, specific IgE positivity, eosinophil count in cutaneous T Cell lymphoma.
Kural YB; Su O; Onsun N; Uras AR
Int J Dermatol; 2010 Apr; 49(4):390-5. PubMed ID: 20465692
[TBL] [Abstract][Full Text] [Related]
51. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.
Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Asano N; Mitsui H; Tada Y; Wakugawa M; Watanabe T; Torii H; Komine M; Asahina A; Nakamura K; Tamaki K
J Allergy Clin Immunol; 2003 Mar; 111(3):592-7. PubMed ID: 12642842
[TBL] [Abstract][Full Text] [Related]
52. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
[TBL] [Abstract][Full Text] [Related]
53. Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Morimura S; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Invest Dermatol; 2012 Apr; 132(4):1280-9. PubMed ID: 22297640
[TBL] [Abstract][Full Text] [Related]
54. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study.
Sigurdsson V; Toonstra J; Bihari IC; Bruijnzeel-Koomen CA; van Vloten WA; Thepen T
J Cutan Pathol; 2000 Oct; 27(9):429-35. PubMed ID: 11028812
[TBL] [Abstract][Full Text] [Related]
55. Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.
Senda N; Miyagaki T; Kamijo H; Nakajima R; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
Eur J Dermatol; 2018 Oct; 28(5):621-627. PubMed ID: 30378541
[TBL] [Abstract][Full Text] [Related]
56. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages.
Dalton SR; Chandler WM; Abuzeid M; Hossler EW; Ferringer T; Elston DM; LeBoit PE
Am J Dermatopathol; 2012 Aug; 34(6):586-91. PubMed ID: 22814317
[TBL] [Abstract][Full Text] [Related]
57. Staging and management of cutaneous T-cell lymphoma.
Scarisbrick JJ
Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
[TBL] [Abstract][Full Text] [Related]
58. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
59. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
Park CW; Lee BH; Han HJ; Lee CH; Ahn HK
Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
[TBL] [Abstract][Full Text] [Related]
60. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]